
Effective engagement of a stakeholder advisory board in severe mental illness (SMI) research: A case study of a clinical trial to improve adherence among people with SMI and hypertension
Author(s) -
Dafna Paltin,
Jessica L. Montoya,
Celeste Weise,
Carla Conroy,
Ethan E. Radatz,
Kurt C. Stange,
David J. Moore,
Martha Sajatovic,
Jennifer Levin
Publication year - 2022
Publication title -
international journal of healthcare
Language(s) - English
Resource type - Journals
eISSN - 2377-7346
pISSN - 2377-7338
DOI - 10.5430/ijh.v8n2p9
Subject(s) - stakeholder engagement , operationalization , randomized controlled trial , mental health , medicine , general partnership , community engagement , intervention (counseling) , psychological intervention , implementation research , stakeholder , psychology , nursing , psychiatry , public relations , philosophy , surgery , epistemology , finance , political science , economics
Poor adherence to antihypertensive medication occurs in 50-80% of patients. An ongoing randomized controlled trial (RCT) is evaluating a personalized mobile-health intervention in poorly adherent hypertensive persons with bipolar disorder. To enhance efficacy, the ongoing trial elicited guidance from a Stakeholder Advisory Board (SAB) comprised of patients, family members, clinicians, and health system administrators. Our goal is to describe the formation, role, decision-making process, and key contributions of the SAB as a means of demonstrating meaningful community engagement in mental health research.